Business

OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100

ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions

articleOptimizerx CorporationMay 17, 20225/company/optimizerx-corp/news/optimizerxs-mike-rousselle-named-one-of-2022-pm360-elite-100
OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100

About this update from Optimizerx Corporation

[{"type":"text","content":"ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced that Mike Rousselle, vice president of data product, has been named one of the 2022 PM360 ELITE 100 in the Data Miners category. The PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represents the most influential people in the healthcare industry today. Rousselle is a data science leader who is passionate about advancing pharmaceutical and healthcare marketing through the application of artificial intelligence (AI) and machine learning (ML) to garner actionable insights. Over the course of his career, Rousselle has remained laser-focused on leveraging the power of AI and ML to develop and deploy products that drive business and human value. At OptimizeRx, Rousselle applies his AI expertise in healthcare and marketing to design tailored data solutions for life sciences clients. He and his team design programs using AI/ML methods applied to real-world data (RWD), to infer what is happening in real-time at the point-of-care, for the purpose of delivering contextual information from life sciences to physicians. This patent-pending, cutting-edge methodology allows pharmaceutical companies to reach target audiences more efficiently, messaging physicians with relevant patient-level information when most needed, making this innovative approach a win-win for life sciences companies and patient outcomes. Steve Silvestro, chief commercial officer at OptimizeRx commented, “Mike has been a transformational addition to our data and AI team. He has helped us implement faster and more efficient ways of ingesting disparate real-world data assets outside the EHR so that we can be smarter about engaging HCPs at the point-of-care. He’s led several initiatives that we’ve undertaken for programs with high levels of complexity, and he’s delivered great results for our clients and partners. Mike and the AI team are focused on innovation that adds value for all stakeholders, giving OptimizeRx a competitive edge as the only company currently able to implement such precise audience targeting and messaging.” The PM360 ELITE Awards were established in 2015 to recognize individuals and teams who have made a signifi...

More updates from Optimizerx Corporation